Diagnostic testing for hepatitis C: Practical considerations

American Journal of Medicine

Volumn 107, Issue 6 SUPPL. 2, 1999, Pages 31-35

  Fried, Michael W ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS CHARACTERIZATION; VIRUS LOAD;

EID: 0033398127     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(99)00378-2     Document Type: Conference Paper

References (7)

1. Recommendations for prevention and control of hepatitis C (HCV) infection and HCV-related chronic disease. MMWR. 47:(RR-19):1998;1-39.
2. Gretch D.R. Use and interpretation of HCV diagnostic tests in the clinical setting. Clin Liver Dis. 1:1997;543-557.
3. Younossi Z., McHutchison J.G. Serological tests for HCV infection. Viral Hepatitis Reviews. 2:1996;161-173.
4. Yamada G., Takatani M., Kishi F., et al. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA levels. Hepatology. 22:1995;1351-1354.
5. Lau J.Y.N., Davis G.L., Knifen J., et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 341:1993;1501-1504.
6. Fried M.W. Clinical application of hepatitis C virus genotyping and quantitation. Clin Liver Dis. 1:1997;631-646.
7. McHutchison J.G., Gordon S.C., Schiff E.R., et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med. 21:1998;1485-1492.